Patient Guide: A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 51 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06830629
Status: 🟢 Enrolling Now
Condition: Proteinuric Kidney Disease
Phase: PHASE2

Where You Can Participate

This study is available at 51 locations across the country.

Top locations include:
  • • Huntsville, Alabama
  • • Montgomery, Alabama
  • • Granada Hills, California
  • • And 48 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease - Join Clinical Trial NCTNCT06830629

How to Join This Clinical Trial - NCTNCT06830629

Learn how to participate in this PHASE2 trial studying an investigational therapy for Proteinuric Kidney Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Proteinuric Kidney Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Proteinuric Kidney Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06830629 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 51 locations. Find a study site near you:

Clinical Research Site

Huntsville, Alabama 35805 - United States

Status: RECRUITING

Clinical Research Site

Montgomery, Alabama 36117 - United States

Status: RECRUITING

Clinical Research Site

Granada Hills, California 91344 - United States

Status: RECRUITING

Clinical Research Site

Palmdale, California 93551 - United States

Status: RECRUITING

Clinical Research Site

Valencia, California 91355 - United States

Status: RECRUITING

Clinical Research Site

Bloomfield, Connecticut 06112 - United States

Status: RECRUITING

Clinical Research Site

Atlantis, Florida 33462 - United States

Status: RECRUITING

Clinical Research Site

Brandon, Florida 33511 - United States

Status: RECRUITING

Clinical Research Site

Brooksville, Florida 34613 - United States

Status: RECRUITING

Clinical Research Site

Hollywood, Florida 33024 - United States

Status: RECRUITING

And 41 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Proteinuric Kidney Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships